Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2005-05-13 Director's Dealing
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2005-05-13 English
10QSB MARCH 31, 2005
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-QSB' and is explicitly described as a 'QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the quarterly period ended March 31, 2005. It contains detailed consolidated financial statements including balance sheets, statements of operations, shareholders' equity, cash flows, and notes to the financial statements. It also includes management's discussion and analysis and other information typical of an interim quarterly report. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is the actual report, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2005-05-13 English
Regulatory Filings 2005
Regulatory Filings Classification · 100% confidence The document is a comment letter from the SEC staff to Bovie Medical Corporation regarding their Amendment No. 2 to Registration Statement on Form S-3 filed April 28, 2005. It contains detailed comments on disclosures, risk factors, financial statements, and other regulatory compliance matters related to the registration statement and incorporated reports such as the annual report on Form 10-KSB for the fiscal year ended December 31, 2004. The letter is not the report itself but a regulatory review communication addressing the registration statement and related filings. It is a regulatory filing related to compliance and review comments rather than a financial report, earnings release, or other specific report type. Therefore, the appropriate classification is Regulatory Filings (RNS).
2005-05-12 English
PRIMARY DOCUMENT
Director's Dealing
2005-05-12 English
PRIMARY DOCUMENT
Director's Dealing
2005-05-11 English
PRIMARY DOCUMENT
Director's Dealing
2005-05-11 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.